ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 128 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $110,546 | +64.3% | 112,802 | +166.6% | 0.00% | – |
| Q1 2023 | $67,263 | -93.3% | 42,304 | -73.7% | 0.00% | -100.0% |
| Q4 2022 | $1,003,890 | -58.5% | 161,138 | -55.4% | 0.01% | -57.1% |
| Q3 2022 | $2,419,000 | +48.7% | 361,052 | +41.1% | 0.01% | +40.0% |
| Q2 2022 | $1,627,000 | +464.9% | 255,837 | +311.9% | 0.01% | +400.0% |
| Q1 2022 | $288,000 | -70.7% | 62,112 | -68.4% | 0.00% | -77.8% |
| Q4 2021 | $984,000 | -44.4% | 196,745 | +33.9% | 0.01% | -59.1% |
| Q3 2021 | $1,771,000 | +455.2% | 146,943 | +874.1% | 0.02% | +450.0% |
| Q2 2021 | $319,000 | -72.4% | 15,085 | -63.3% | 0.00% | -73.3% |
| Q1 2021 | $1,154,000 | +37.7% | 41,129 | +27.6% | 0.02% | +25.0% |
| Q4 2020 | $838,000 | +7.6% | 32,232 | +53.8% | 0.01% | 0.0% |
| Q3 2020 | $779,000 | +533.3% | 20,960 | +773.3% | 0.01% | +500.0% |
| Q2 2020 | $123,000 | -85.2% | 2,400 | -90.9% | 0.00% | -91.3% |
| Q1 2020 | $833,000 | -64.9% | 26,435 | -33.6% | 0.02% | -47.7% |
| Q4 2019 | $2,375,000 | +1075.7% | 39,824 | +624.1% | 0.04% | +1000.0% |
| Q3 2019 | $202,000 | -82.7% | 5,500 | -78.2% | 0.00% | -81.8% |
| Q2 2019 | $1,171,000 | +122.6% | 25,179 | +92.1% | 0.02% | +29.4% |
| Q1 2019 | $526,000 | -26.4% | 13,106 | -15.6% | 0.02% | -50.0% |
| Q4 2018 | $715,000 | +376.7% | 15,534 | +359.0% | 0.03% | +325.0% |
| Q3 2018 | $150,000 | -8.0% | 3,384 | -18.6% | 0.01% | 0.0% |
| Q2 2018 | $163,000 | -78.4% | 4,156 | -60.2% | 0.01% | -81.8% |
| Q1 2018 | $755,000 | +186.0% | 10,444 | -11.9% | 0.04% | +193.3% |
| Q4 2015 | $264,000 | +725.0% | 11,854 | +783.3% | 0.02% | +650.0% |
| Q3 2015 | $32,000 | -27.3% | 1,342 | +149.4% | 0.00% | 0.0% |
| Q2 2015 | $44,000 | -93.8% | 538 | -92.9% | 0.00% | -94.1% |
| Q1 2015 | $704,000 | +188.5% | 7,601 | +26.2% | 0.03% | +161.5% |
| Q4 2014 | $244,000 | – | 6,024 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,679,835 | $69,675,000 | 19.39% |
| Endurant Capital Management LP | 207,293 | $5,390,000 | 1.94% |
| Bellevue Group AG | 5,138,451 | $133,599,000 | 1.53% |
| Rhenman & Partners Asset Management AB | 592,225 | $15,398,000 | 1.26% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,562,869 | $40,635,000 | 0.93% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 31,434 | $817,000 | 0.62% |
| WASATCH ADVISORS LP | 3,998,010 | $103,949,000 | 0.51% |
| HAMILTON LANE ADVISORS LLC | 46,181 | $1,201,000 | 0.45% |
| Boxer Capital, LLC | 500,000 | $13,000,000 | 0.42% |
| DCF Advisers, LLC | 38,500 | $1,001,000 | 0.41% |